SequelSEC

VIEMED HEALTHCARE, INC. VMD

Services-Misc Health & Allied Services, NEC · CIK 0001729149 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$301.61M
Fiscal year ended 2026-06-30
Operating income
$22.77M
Fiscal year ended 2026-06-30
Free cash flow
$29.24M
Fiscal year ended 2026-06-30

VIEMED HEALTHCARE, INC. (VMD) reported revenue of $301.61M and net income of $14.50M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from VIEMED HEALTHCARE, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Misc Health & Allied Services, NEC.

Income

VIEMED HEALTHCARE, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$301.61M
Cost of revenue$128.28M
Gross profit$173.32M
Operating income$22.77M
Net income$14.50M
Research & development$2.46M
Weighted-average diluted sharesUnavailable
Pretax income$21.18M
Income tax expense$6.16M
Diluted EPSUnavailable
Selling, general & administrative$136.06M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

VIEMED HEALTHCARE, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$10.68M
Total assets$204.22M
Current assets$53.96M
Total liabilities$58.26M
Current liabilities$47.89M
Total equity incl. NCI$145.96M
Temporary (mezzanine) equityUnavailable
Inventory$5.27M
Accounts receivable$32.23M
Goodwill$58.94M
Long-term debt$6.37M
Accounts payableUnavailable

Cash flow

VIEMED HEALTHCARE, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$60.78M
Capital expenditures$31.54M
Investing cash flow-$53.23M
Financing cash flow-$16.88M
Net change in cash-$9.34M
Stock-based compensation$8.96M
Common dividends paidUnavailable
Common share repurchases$18.32M
Depreciation & amortization$15.98M

Derived

VIEMED HEALTHCARE, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$29.24M
Gross margin57.5%
Operating margin7.5%
FCF margin9.7%
SBC / revenue3.0%
Current ratio1.13x
Revenue YoY growth25.2%
Net margin4.8%
R&D / revenue0.8%
CapEx / revenue10.5%
Long-term debt / equity0.04x
Effective tax rate29.1%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VMD in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-03View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-03-04View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

AGL BRTX CCEL DVA MGRX MRAI PARK PFHO PGNY SHC

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.